Global Neuromodulation Market Size, Share & Industry Trends Analysis Report By Technology (Internal and External), By Biomaterial, By Application, By Regional Outlook and Forecast, 2022 - 2028

The Global Neuromodulation Market size is expected to reach $3.8 billion by 2028, rising at a Market growth of 6.0% CAGR during the forecast period.

Neuromodulators are a type of neurotransmitter that is a subgroup of neurotransmitters. Neuromodulators, unlike neurotransmitters, are released in a diffused way. This indicates that exposure to the neuromodulator could expose a complete neural tissue to its effects. As a result, the neuronal circuitry of an entire brain region, rather than simply a single neuron, may be tuned.

The growing incidence of various types of neurological illnesses, such as Alzheimer's disease, dementia, stroke, and brain tumors, is driving the expansion of the neuromodulation Market. The increase in the prevalence of brain illnesses and the use of neuromodulation devices in developed nations are both contributing to the expansion of the neuromodulation Market share. Deep brain stimulation (DBS) is a technique for treating epilepsy and Parkinson's disease. The Market for neuromodulation is growing as the prevalence of epilepsy rises. Epilepsy, for example, is a chronic non-communicable brain disorder that affects people of all ages, according to the World Health Organization (WHO) in February 2022. According to the same source, around 50 million people across the world have been diagnosed with epilepsy.

Furthermore, the increase in the geriatric population aided the Market 's expansion. Alzheimer's along with other neurological disorders are more common in the elderly population. According to the Alzheimer's Association, a non-profit organization, approximately 6.2 million Americans aged 65 and older were diagnosed with Alzheimer's dementia in 2021.

COVID-19 Impact Analysis

Since most hospitals are closed owing to continuous lockdowns in numerous countries, the COVID-19 pandemic has had a negative effect on the neuromodulation Market 's growth. COVID-19's spread resulted in severe public health concerns. However, a large number of clinics and hospitals around the world have been reformed in order to improve hospital capacity and deliver better healthcare. In addition, neuromodulation sales have decreased across multiple regions due to a fall in both new patient and service implant procedures. Plenty of people who otherwise would have gotten tested for their mental illnesses has had to avoid visiting hospitals because of the risk of the infection. In most countries around the world, only patients with severe conditions were allowed to visit hospitals since the hospital beds were all occupied by severely afflicted COVID-19 patients.

Market Growth Factors

Rising Demand for Deep Brain Stimulation

Deep brain stimulation (DBS) uses electrodes coupled to a pulse generator implanted in the patient's body to continuously administer low bipolar or monopolar electric impulses, activating a tiny portion of the brain. DBS is used to treat pain, epilepsy, movement disorders like tremors, Parkinson's disease, dystonia, and psychiatric disorders like Tourette syndrome, obsessive-compulsive disorder, and depression, among others. Manufacturers are now working to improve their existing DBS systems while also designing the next generation of devices. DBS is being targeted to different parts of the brain by researchers, who are testing the treatment on distinct groups of Parkinson's patients.

Rising Incidence of drug resistant chronic conditions

A considerable number of the patient population suffering from chronic illnesses such as chronic back pain, depression, epilepsy, and sleep apnea, among others, is displaying medication and drug resistance. Resistance manifests itself in the form of slow treatment progression and delayed or limited effects. As a result, healthcare professionals are focusing more on neurostimulation techniques for the treatment of chronic illnesses, which is propelling the neuromodulation devices Market forward. Epilepsy, treatment-resistant depression, and other chronic diseases impose a significant financial burden on countries in terms of patient treatment.

Market Restraining Factors

Low Diagnosis and Treatment Rates in Developing Countries

In developing countries, the prevalence of neurological diseases such as epilepsy, depression, and others is increasing at an incredible rate. Despite having a substantially larger frequency, emerging countries have lower diagnostic rates, which limits the number of individuals who require treatment. Lower diagnosis rates in these nations are attributed to a variety of causes, including a lack of public awareness and limited access to diagnostic facilities due to inadequate healthcare infrastructure. Low income is also one of the leading factors which forbid some people from visiting the hospital and getting tests done to arrive at the correct diagnosis.

Technology Outlook

Based on Technology, the Market is segmented into Internal and External. The internal segment acquired the largest revenue share in the neuromodulation Market in 2021. The significant demand for this technology is due to the growing incidence rate of the chronic leg, back, and arm pain, as well as the applicability of this technology in the effective management of these chronic pains. Due to an increase in the incidence of Parkinson's disease and an increase in product approval for neurological disease treatment, the internal modulation technology would be in demand in the upcoming years.

Biomaterial Outlook

Based on Biomaterial, the Market is segmented into Metallic, Polymeric, and Ceramic. The polymeric segment procured a substantial revenue share in the neuromodulation Market in 2021. Polymeric biomaterials (biopolymers) are materials that can be employed for long or short periods of time in physiological conditions. Polymeric biomaterials cover the widest range of synthetic and hybrid materials now employed in medicine. This factor is increasing the growth of this segment of the neuromodulation Market .

Application Outlook

Based on Application, the Market is segmented into Chronic Pain, Urinary & Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, and Others. The chronic pain segment acquired the largest revenue share in the neuromodulation Market in 2021. Due to an increase in the prevalence of chronic disease and increased R&D activity in the healthcare sector, the demand for neuromodulation in rapidly surging. In addition, the increasing adoption of sedentary lifestyle in people all over the world is one of the major factors that is increasing the instances of chronic pain in these people. This factor would play a major role in accelerating the growth of this segment.

Neuromodulation Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 2.6 Billion
Market size forecast in 2028	USD 3.8 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 6% from 2022 to 2028
Number of Pages	241
Number of Tables	405
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Technology, Biomaterial, Application, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising Demand for Deep Brain Stimulation Rising Incidence of drug resistant chronic conditions
Restraints	Low Diagnosis and Treatment Rates in Developing Countries

Regional Outlook

Based on Regions, the Market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America acquired the largest revenue share in the neuromodulation Market in 2021. The significant growth of the regional Market is attributed to the rise in prevalence of neurological diseases, the presence of key players in the regional neuromodulation Market , and well-established infrastructure in the region. The presence of key Market players and large pharmaceutical and biopharmaceutical industries, as well as increased investments in the country for the adoption of innovative technologies, is likely to support the regional Market 's expansion.

Free Valuable Insights: Global Neuromodulation Market size to reach USD 3.8 Billion by 2028

KBV Cardinal Matrix - Neuromodulation Market Competition Analysis

The major strategies followed by the Market participants are Approvals and Trials. Based on the Analysis presented in the Cardinal matrix; Abbott Laboratories is the forerunners in the Neuromodulation Market . Companies such as MicroTransponder Inc., Boston Scientific Corporation are some of the key innovators in the Market .

The Market research report covers the analysis of key stake holders of the Market . Key companies profiled in the report include Medtronic PLC, LivaNova PLC, Boston Scientific Corporation, Abbott Laboratories, Nevro Corporation, NeuroSigma, Inc., NeuroPace, Inc., Neuronetics, Inc., MicroTransponder Inc., and Bioventus Inc.

Recent Strategies Deployed in Neuromodulation Market

» Partnerships, Collaborations and Agreements

• Jun-2021: NeuroSigma entered into a partnership with KT Corporation, a telecommunication company based in South Korea. The partnership aimed at developing and commercializing, inside and outside of Korea, electronic therapies treating neurological and neuropsychological disorders, such as depression, ADHD, and epilepsy. Through this partnership with NeuroSigma, KT supported the design and development of the next-generation category of eTNS products integrating big data, artificial intelligence (AI), and cloud capabilities. Additionally, KT also supported advanced monitoring and AI analysis services, offered via its digital healthcare platform, and the commercialization and manufacturing partnerships in Korea.
• Feb-2020: LivaNova teamed up with Verily, an Alphabet company. The collaboration aimed at capturing measures of depression within its RECOVER clinical study, which was analyzing the efficacy of Vagus Nerve Stimulation Therapy (VNS Therapy) for difficult-to-treat Depression (DTD). Under the collaboration with Verily, LivaNova built on its work to study depression and understand the complicated elements that contribute to the disorder, improving its capacity to treat patients who have it.
• Oct-2019: NeuroSigma entered into a partnership with Teijin Limited, a chemical, pharmaceutical, and information technology company based in Japan. The partnership granted Teijin Pharma, Teijin's healthcare business, exclusive rights to NeuroSigma's TNS patent rights in Japan related to attention deficit hyperactivity disorder (ADHD), and Market the Monarch eTNS System for the non-invasive treatment of ADHD in Japan.

» Approvals and Trials

• Mar-2022: Bioventus received FDA approval for the next generation StimRouter Neuromodulation System. This system is used for the therapy of chronic pain of peripheral nerve origin, excluding craniofacial pain. The newly approved StimRouter system offers a similar clinically tested, long-term pain relief while substantially improving the patient's control and user experience.
• Jan-2022: Nevro received FDA approval for expanded labeling for its Senza Spinal Cord Stimulation (SCS) System for the treatment of Non-Surgical Refractory Back Pain (NSRBP). The SENZA-NSRBP study participants who were given 10 kHz Therapy showed great improvements in function, pain relief, awareness of positive change in quality of life, and reduction in everyday opioid use versus Conventional Medical Management.
• Aug-2021: MicroTransponder received FDA approval for Vivistim paired VNS system for chronic ischemic stroke rehabilitation. This system, Vivistim electrically stimulates the vagus nerve to decrease deficiencies in upper limb and extremity motor function and to enhance patients’ capacity to move their arms and hands. Under the skin in the patient's chest, an implantable pulse generator is implanted with a lead wire that leads up to electrodes placed on the left side of the neck where the vagus nerve is.
• Jun-2021: LivaNova received FDA approval for proceeding with its, “Treating Obstructive Sleep Apnea using Targeted Hypoglossal Neurostimulation (OSPREY)”, an investigational device exemption (IDE) clinical study. The aura6000 was developed to sustain muscle tone of the tongue and upper airway so that airway blockage and resulting sleep apnea are substantially decreased or removed. The OSPREY study was used to analyze the apnea-hypopnea index responder rate of subjects with device stimulation activated to decide whether it is statistically higher than the rate of subjects without stimulation. The overall safety and efficacy of the device in its ability to treat patients with OSA were evaluated.

» Acquisitions and Mergers

• Aug-2021: Medtronic acquired Intersect ENT, a world leader in ear, nose, and throat (ENT) medical technology devoted to transforming patient care. The acquisition enabled Medtronic to expand its portfolio of products used during ear, nose, and throat procedures. The complementary customer base and product lines would further enhance Medtronic's efforts to have a positive impact on patients who suffer from chronic rhinosinusitis (CRS).
• Mar-2021: Bioventus completed the acquisition of Bioness, a key player in neuromodulation and rehabilitation medical equipment through its ingenious peripheral nerve stimulation therapy and premium rehabilitation solutions. The acquisition matched Bioventus’ goal of assisting patients to regain active lifestyles and the strategy of accretive revenue growth through acquisitions that leverage the Company’s existing infrastructure.
• Jan-2020: Medtronic completed the acquisition of Stimgenics, the pioneer of a new spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM) Spinal Cord Stimulation. The therapy is a novel and distinctive programming option to treat patients with chronic pain. It is delivered via the Medtronic Intellis platform. The DTM waveform had a more significant impact on the neural-glial interaction than other frequencies.

» Product Launches and Product Expansions

• May-2022: Medtronic unveiled CareGuidePro, a smartphone application and web portal. CareGuidePro is Medtronic's foremost patient-centric digital health system designed for spinal cord stimulation patients, planned as a seamless solution that would merge into the care provider's workflow. This digital health system paves the way for a more engaging and informative patient experience that results in a better physician-patient dialogue, leading to improved therapy management.
• Mar-2021: Abbott launched NeuroSphere Virtual Clinic, an unparalleled technology that permits patients to communicate with physicians, ensure proper settings and functionality, and receive new treatment settings remotely as required. Through this product, Physicians can communicate and digitally prescribe new stimulation settings remotely, enabling them to expand care beyond their clinic walls and optimize therapy management using NeuroSphere Virtual Clinic.

» Geographical Expansions

• Mar-2022: Boston Scientific Corporation expanded its geographical footprint by launching its R&D Center in Pune. The expansion aimed to capitalize on the country’s R&D expertise and offer varied opportunities for engineers and innovators in India. The R&D Center provided expertise to all of the company's therapy areas, specifically peripheral interventions, interventional cardiology, cardiac rhythm management, neuromodulation, endoscopy, and urology and pelvic health. The R&D team provided support in the fields of software engineering, mechanical design, and analysis, sustaining engineering, quality, and compliance.

Scope of the Study

Market Segments Covered in the Report:

By Technology

• Internal
• External

By Biomaterial

• Metallic
• Polymeric
• Ceramic

By Application

• Chronic Pain
• Urinary & Fecal Incontinence
• Migraine
• Failed Back Syndrome
• Parkinson Disease
• Epilepsy
• Tremor
• Depression
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Medtronic PLC
• LivaNova PLC
• Boston Scientific Corporation
• Abbott Laboratories
• Nevro Corporation
• NeuroSigma, Inc.
• NeuroPace, Inc.
• Neuronetics, Inc.
• MicroTransponder Inc.
• Bioventus Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Neuromodulation Market, by Technology
1.4.2 Global Neuromodulation Market, by Biomaterial
1.4.3 Global Neuromodulation Market, by Application
1.4.4 Global Neuromodulation Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Approvals and Trials
3.2.3 Product Launches and Product Expansions
3.2.4 Acquisition and Mergers
3.2.5 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Neuromodulation Market by Technology
4.1 Global Internal Market by Region
4.2 Global External Market by Region

Chapter 5. Global Neuromodulation Market by Biomaterial
5.1 Global Metallic Market by Region
5.2 Global Polymeric Market by Region
5.3 Global Ceramic Market by Region

Chapter 6. Global Neuromodulation Market by Application
6.1 Global Chronic Pain Market by Region
6.2 Global Urinary & Fecal Incontinence Market by Region
6.3 Global Migraine Market by Region
6.4 Global Failed Back Syndrome Market by Region
6.5 Global Parkinson Disease Market by Region
6.6 Global Epilepsy Market by Region
6.7 Global Tremor Market by Region
6.8 Global Depression Market by Region
6.9 Global Others Market by Region

Chapter 7. Global Neuromodulation Market by Region
7.1 North America Neuromodulation Market
7.1.1 North America Neuromodulation Market by Technology
7.1.1.1 North America Internal Market by Country
7.1.1.2 North America External Market by Country
7.1.2 North America Neuromodulation Market by Biomaterial
7.1.2.1 North America Metallic Market by Country
7.1.2.2 North America Polymeric Market by Country
7.1.2.3 North America Ceramic Market by Country
7.1.3 North America Neuromodulation Market by Application
7.1.3.1 North America Chronic Pain Market by Country
7.1.3.2 North America Urinary & Fecal Incontinence Market by Country
7.1.3.3 North America Migraine Market by Country
7.1.3.4 North America Failed Back Syndrome Market by Country
7.1.3.5 North America Parkinson Disease Market by Country
7.1.3.6 North America Epilepsy Market by Country
7.1.3.7 North America Tremor Market by Country
7.1.3.8 North America Depression Market by Country
7.1.3.9 North America Others Market by Country
7.1.4 North America Neuromodulation Market by Country
7.1.4.1 US Neuromodulation Market
7.1.4.1.1 US Neuromodulation Market by Technology
7.1.4.1.2 US Neuromodulation Market by Biomaterial
7.1.4.1.3 US Neuromodulation Market by Application
7.1.4.2 Canada Neuromodulation Market
7.1.4.2.1 Canada Neuromodulation Market by Technology
7.1.4.2.2 Canada Neuromodulation Market by Biomaterial
7.1.4.2.3 Canada Neuromodulation Market by Application
7.1.4.3 Mexico Neuromodulation Market
7.1.4.3.1 Mexico Neuromodulation Market by Technology
7.1.4.3.2 Mexico Neuromodulation Market by Biomaterial
7.1.4.3.3 Mexico Neuromodulation Market by Application
7.1.4.4 Rest of North America Neuromodulation Market
7.1.4.4.1 Rest of North America Neuromodulation Market by Technology
7.1.4.4.2 Rest of North America Neuromodulation Market by Biomaterial
7.1.4.4.3 Rest of North America Neuromodulation Market by Application
7.2 Europe Neuromodulation Market
7.2.1 Europe Neuromodulation Market by Technology
7.2.1.1 Europe Internal Market by Country
7.2.1.2 Europe External Market by Country
7.2.2 Europe Neuromodulation Market by Biomaterial
7.2.2.1 Europe Metallic Market by Country
7.2.2.2 Europe Polymeric Market by Country
7.2.2.3 Europe Ceramic Market by Country
7.2.3 Europe Neuromodulation Market by Application
7.2.3.1 Europe Chronic Pain Market by Country
7.2.3.2 Europe Urinary & Fecal Incontinence Market by Country
7.2.3.3 Europe Migraine Market by Country
7.2.3.4 Europe Failed Back Syndrome Market by Country
7.2.3.5 Europe Parkinson Disease Market by Country
7.2.3.6 Europe Epilepsy Market by Country
7.2.3.7 Europe Tremor Market by Country
7.2.3.8 Europe Depression Market by Country
7.2.3.9 Europe Others Market by Country
7.2.4 Europe Neuromodulation Market by Country
7.2.4.1 Germany Neuromodulation Market
7.2.4.1.1 Germany Neuromodulation Market by Technology
7.2.4.1.2 Germany Neuromodulation Market by Biomaterial
7.2.4.1.3 Germany Neuromodulation Market by Application
7.2.4.2 UK Neuromodulation Market
7.2.4.2.1 UK Neuromodulation Market by Technology
7.2.4.2.2 UK Neuromodulation Market by Biomaterial
7.2.4.2.3 UK Neuromodulation Market by Application
7.2.4.3 France Neuromodulation Market
7.2.4.3.1 France Neuromodulation Market by Technology
7.2.4.3.2 France Neuromodulation Market by Biomaterial
7.2.4.3.3 France Neuromodulation Market by Application
7.2.4.4 Russia Neuromodulation Market
7.2.4.4.1 Russia Neuromodulation Market by Technology
7.2.4.4.2 Russia Neuromodulation Market by Biomaterial
7.2.4.4.3 Russia Neuromodulation Market by Application
7.2.4.5 Spain Neuromodulation Market
7.2.4.5.1 Spain Neuromodulation Market by Technology
7.2.4.5.2 Spain Neuromodulation Market by Biomaterial
7.2.4.5.3 Spain Neuromodulation Market by Application
7.2.4.6 Italy Neuromodulation Market
7.2.4.6.1 Italy Neuromodulation Market by Technology
7.2.4.6.2 Italy Neuromodulation Market by Biomaterial
7.2.4.6.3 Italy Neuromodulation Market by Application
7.2.4.7 Rest of Europe Neuromodulation Market
7.2.4.7.1 Rest of Europe Neuromodulation Market by Technology
7.2.4.7.2 Rest of Europe Neuromodulation Market by Biomaterial
7.2.4.7.3 Rest of Europe Neuromodulation Market by Application
7.3 Asia Pacific Neuromodulation Market
7.3.1 Asia Pacific Neuromodulation Market by Technology
7.3.1.1 Asia Pacific Internal Market by Country
7.3.1.2 Asia Pacific External Market by Country
7.3.2 Asia Pacific Neuromodulation Market by Biomaterial
7.3.2.1 Asia Pacific Metallic Market by Country
7.3.2.2 Asia Pacific Polymeric Market by Country
7.3.2.3 Asia Pacific Ceramic Market by Country
7.3.3 Asia Pacific Neuromodulation Market by Application
7.3.3.1 Asia Pacific Chronic Pain Market by Country
7.3.3.2 Asia Pacific Urinary & Fecal Incontinence Market by Country
7.3.3.3 Asia Pacific Migraine Market by Country
7.3.3.4 Asia Pacific Failed Back Syndrome Market by Country
7.3.3.5 Asia Pacific Parkinson Disease Market by Country
7.3.3.6 Asia Pacific Epilepsy Market by Country
7.3.3.7 Asia Pacific Tremor Market by Country
7.3.3.8 Asia Pacific Depression Market by Country
7.3.3.9 Asia Pacific Others Market by Country
7.3.4 Asia Pacific Neuromodulation Market by Country
7.3.4.1 China Neuromodulation Market
7.3.4.1.1 China Neuromodulation Market by Technology
7.3.4.1.2 China Neuromodulation Market by Biomaterial
7.3.4.1.3 China Neuromodulation Market by Application
7.3.4.2 Japan Neuromodulation Market
7.3.4.2.1 Japan Neuromodulation Market by Technology
7.3.4.2.2 Japan Neuromodulation Market by Biomaterial
7.3.4.2.3 Japan Neuromodulation Market by Application
7.3.4.3 India Neuromodulation Market
7.3.4.3.1 India Neuromodulation Market by Technology
7.3.4.3.2 India Neuromodulation Market by Biomaterial
7.3.4.3.3 India Neuromodulation Market by Application
7.3.4.4 South Korea Neuromodulation Market
7.3.4.4.1 South Korea Neuromodulation Market by Technology
7.3.4.4.2 South Korea Neuromodulation Market by Biomaterial
7.3.4.4.3 South Korea Neuromodulation Market by Application
7.3.4.5 Singapore Neuromodulation Market
7.3.4.5.1 Singapore Neuromodulation Market by Technology
7.3.4.5.2 Singapore Neuromodulation Market by Biomaterial
7.3.4.5.3 Singapore Neuromodulation Market by Application
7.3.4.6 Malaysia Neuromodulation Market
7.3.4.6.1 Malaysia Neuromodulation Market by Technology
7.3.4.6.2 Malaysia Neuromodulation Market by Biomaterial
7.3.4.6.3 Malaysia Neuromodulation Market by Application
7.3.4.7 Rest of Asia Pacific Neuromodulation Market
7.3.4.7.1 Rest of Asia Pacific Neuromodulation Market by Technology
7.3.4.7.2 Rest of Asia Pacific Neuromodulation Market by Biomaterial
7.3.4.7.3 Rest of Asia Pacific Neuromodulation Market by Application
7.4 LAMEA Neuromodulation Market
7.4.1 LAMEA Neuromodulation Market by Technology
7.4.1.1 LAMEA Internal Market by Country
7.4.1.2 LAMEA External Market by Country
7.4.2 LAMEA Neuromodulation Market by Biomaterial
7.4.2.1 LAMEA Metallic Market by Country
7.4.2.2 LAMEA Polymeric Market by Country
7.4.2.3 LAMEA Ceramic Market by Country
7.4.3 LAMEA Neuromodulation Market by Application
7.4.3.1 LAMEA Chronic Pain Market by Country
7.4.3.2 LAMEA Urinary & Fecal Incontinence Market by Country
7.4.3.3 LAMEA Migraine Market by Country
7.4.3.4 LAMEA Failed Back Syndrome Market by Country
7.4.3.5 LAMEA Parkinson Disease Market by Country
7.4.3.6 LAMEA Epilepsy Market by Country
7.4.3.7 LAMEA Tremor Market by Country
7.4.3.8 LAMEA Depression Market by Country
7.4.3.9 LAMEA Others Market by Country
7.4.4 LAMEA Neuromodulation Market by Country
7.4.4.1 Brazil Neuromodulation Market
7.4.4.1.1 Brazil Neuromodulation Market by Technology
7.4.4.1.2 Brazil Neuromodulation Market by Biomaterial
7.4.4.1.3 Brazil Neuromodulation Market by Application
7.4.4.2 Argentina Neuromodulation Market
7.4.4.2.1 Argentina Neuromodulation Market by Technology
7.4.4.2.2 Argentina Neuromodulation Market by Biomaterial
7.4.4.2.3 Argentina Neuromodulation Market by Application
7.4.4.3 UAE Neuromodulation Market
7.4.4.3.1 UAE Neuromodulation Market by Technology
7.4.4.3.2 UAE Neuromodulation Market by Biomaterial
7.4.4.3.3 UAE Neuromodulation Market by Application
7.4.4.4 Saudi Arabia Neuromodulation Market
7.4.4.4.1 Saudi Arabia Neuromodulation Market by Technology
7.4.4.4.2 Saudi Arabia Neuromodulation Market by Biomaterial
7.4.4.4.3 Saudi Arabia Neuromodulation Market by Application
7.4.4.5 South Africa Neuromodulation Market
7.4.4.5.1 South Africa Neuromodulation Market by Technology
7.4.4.5.2 South Africa Neuromodulation Market by Biomaterial
7.4.4.5.3 South Africa Neuromodulation Market by Application
7.4.4.6 Nigeria Neuromodulation Market
7.4.4.6.1 Nigeria Neuromodulation Market by Technology
7.4.4.6.2 Nigeria Neuromodulation Market by Biomaterial
7.4.4.6.3 Nigeria Neuromodulation Market by Application
7.4.4.7 Rest of LAMEA Neuromodulation Market
7.4.4.7.1 Rest of LAMEA Neuromodulation Market by Technology
7.4.4.7.2 Rest of LAMEA Neuromodulation Market by Biomaterial
7.4.4.7.3 Rest of LAMEA Neuromodulation Market by Application

Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.2 LivaNova PLC
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Approvals and Trials:
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Geographical Expansions:
8.4 Abbott Laboratories
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Nevro Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Approvals and Trials:
8.6 NeuroSigma, Inc.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.7 NeuroPace, Inc.
8.7.1 Company Overview
8.7.2 Recent Strategies and Developments:
8.7.2.1 Product Launches and Product Expansions:
8.8 Neuronetics, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Regional Analysis
8.8.4 Research & Development Expense
8.9 MicroTransponder Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Approvals and Trials:
8.10. Bioventus Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Approvals and Trials:
8.10.5.2 Acquisition and Mergers:

TABLE 1 Global Neuromodulation Market, 2018 - 2021, USD Million
TABLE 2 Global Neuromodulation Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Neuromodulation Market
TABLE 4 Approvals and Trials - NEUROMODULATION MARKET
TABLE 5 Product Launches And Product Expansions– Neuromodulation Market
TABLE 6 Acquisition and Mergers– Neuromodulation Market
TABLE 7 Geographical Expansions- Neuromodulation Market
TABLE 8 Global Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 9 Global Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 10 Global Internal Market by Region, 2018 - 2021, USD Million
TABLE 11 Global Internal Market by Region, 2022 - 2028, USD Million
TABLE 12 Global External Market by Region, 2018 - 2021, USD Million
TABLE 13 Global External Market by Region, 2022 - 2028, USD Million
TABLE 14 Global Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 15 Global Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 16 Global Metallic Market by Region, 2018 - 2021, USD Million
TABLE 17 Global Metallic Market by Region, 2022 - 2028, USD Million
TABLE 18 Global Polymeric Market by Region, 2018 - 2021, USD Million
TABLE 19 Global Polymeric Market by Region, 2022 - 2028, USD Million
TABLE 20 Global Ceramic Market by Region, 2018 - 2021, USD Million
TABLE 21 Global Ceramic Market by Region, 2022 - 2028, USD Million
TABLE 22 Global Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 23 Global Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 24 Global Chronic Pain Market by Region, 2018 - 2021, USD Million
TABLE 25 Global Chronic Pain Market by Region, 2022 - 2028, USD Million
TABLE 26 Global Urinary & Fecal Incontinence Market by Region, 2018 - 2021, USD Million
TABLE 27 Global Urinary & Fecal Incontinence Market by Region, 2022 - 2028, USD Million
TABLE 28 Global Migraine Market by Region, 2018 - 2021, USD Million
TABLE 29 Global Migraine Market by Region, 2022 - 2028, USD Million
TABLE 30 Global Failed Back Syndrome Market by Region, 2018 - 2021, USD Million
TABLE 31 Global Failed Back Syndrome Market by Region, 2022 - 2028, USD Million
TABLE 32 Global Parkinson Disease Market by Region, 2018 - 2021, USD Million
TABLE 33 Global Parkinson Disease Market by Region, 2022 - 2028, USD Million
TABLE 34 Global Epilepsy Market by Region, 2018 - 2021, USD Million
TABLE 35 Global Epilepsy Market by Region, 2022 - 2028, USD Million
TABLE 36 Global Tremor Market by Region, 2018 - 2021, USD Million
TABLE 37 Global Tremor Market by Region, 2022 - 2028, USD Million
TABLE 38 Global Depression Market by Region, 2018 - 2021, USD Million
TABLE 39 Global Depression Market by Region, 2022 - 2028, USD Million
TABLE 40 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 41 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 42 Global Neuromodulation Market by Region, 2018 - 2021, USD Million
TABLE 43 Global Neuromodulation Market by Region, 2022 - 2028, USD Million
TABLE 44 North America Neuromodulation Market, 2018 - 2021, USD Million
TABLE 45 North America Neuromodulation Market, 2022 - 2028, USD Million
TABLE 46 North America Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 47 North America Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 48 North America Internal Market by Country, 2018 - 2021, USD Million
TABLE 49 North America Internal Market by Country, 2022 - 2028, USD Million
TABLE 50 North America External Market by Country, 2018 - 2021, USD Million
TABLE 51 North America External Market by Country, 2022 - 2028, USD Million
TABLE 52 North America Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 53 North America Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 54 North America Metallic Market by Country, 2018 - 2021, USD Million
TABLE 55 North America Metallic Market by Country, 2022 - 2028, USD Million
TABLE 56 North America Polymeric Market by Country, 2018 - 2021, USD Million
TABLE 57 North America Polymeric Market by Country, 2022 - 2028, USD Million
TABLE 58 North America Ceramic Market by Country, 2018 - 2021, USD Million
TABLE 59 North America Ceramic Market by Country, 2022 - 2028, USD Million
TABLE 60 North America Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 61 North America Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 62 North America Chronic Pain Market by Country, 2018 - 2021, USD Million
TABLE 63 North America Chronic Pain Market by Country, 2022 - 2028, USD Million
TABLE 64 North America Urinary & Fecal Incontinence Market by Country, 2018 - 2021, USD Million
TABLE 65 North America Urinary & Fecal Incontinence Market by Country, 2022 - 2028, USD Million
TABLE 66 North America Migraine Market by Country, 2018 - 2021, USD Million
TABLE 67 North America Migraine Market by Country, 2022 - 2028, USD Million
TABLE 68 North America Failed Back Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 69 North America Failed Back Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 70 North America Parkinson Disease Market by Country, 2018 - 2021, USD Million
TABLE 71 North America Parkinson Disease Market by Country, 2022 - 2028, USD Million
TABLE 72 North America Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 73 North America Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 74 North America Tremor Market by Country, 2018 - 2021, USD Million
TABLE 75 North America Tremor Market by Country, 2022 - 2028, USD Million
TABLE 76 North America Depression Market by Country, 2018 - 2021, USD Million
TABLE 77 North America Depression Market by Country, 2022 - 2028, USD Million
TABLE 78 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 79 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 80 North America Neuromodulation Market by Country, 2018 - 2021, USD Million
TABLE 81 North America Neuromodulation Market by Country, 2022 - 2028, USD Million
TABLE 82 US Neuromodulation Market, 2018 - 2021, USD Million
TABLE 83 US Neuromodulation Market, 2022 - 2028, USD Million
TABLE 84 US Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 85 US Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 86 US Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 87 US Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 88 US Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 89 US Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 90 Canada Neuromodulation Market, 2018 - 2021, USD Million
TABLE 91 Canada Neuromodulation Market, 2022 - 2028, USD Million
TABLE 92 Canada Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 93 Canada Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 94 Canada Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 95 Canada Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 96 Canada Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 97 Canada Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 98 Mexico Neuromodulation Market, 2018 - 2021, USD Million
TABLE 99 Mexico Neuromodulation Market, 2022 - 2028, USD Million
TABLE 100 Mexico Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 101 Mexico Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 102 Mexico Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 103 Mexico Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 104 Mexico Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 105 Mexico Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 106 Rest of North America Neuromodulation Market, 2018 - 2021, USD Million
TABLE 107 Rest of North America Neuromodulation Market, 2022 - 2028, USD Million
TABLE 108 Rest of North America Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 109 Rest of North America Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 110 Rest of North America Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 111 Rest of North America Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 112 Rest of North America Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 113 Rest of North America Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 114 Europe Neuromodulation Market, 2018 - 2021, USD Million
TABLE 115 Europe Neuromodulation Market, 2022 - 2028, USD Million
TABLE 116 Europe Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 117 Europe Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 118 Europe Internal Market by Country, 2018 - 2021, USD Million
TABLE 119 Europe Internal Market by Country, 2022 - 2028, USD Million
TABLE 120 Europe External Market by Country, 2018 - 2021, USD Million
TABLE 121 Europe External Market by Country, 2022 - 2028, USD Million
TABLE 122 Europe Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 123 Europe Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 124 Europe Metallic Market by Country, 2018 - 2021, USD Million
TABLE 125 Europe Metallic Market by Country, 2022 - 2028, USD Million
TABLE 126 Europe Polymeric Market by Country, 2018 - 2021, USD Million
TABLE 127 Europe Polymeric Market by Country, 2022 - 2028, USD Million
TABLE 128 Europe Ceramic Market by Country, 2018 - 2021, USD Million
TABLE 129 Europe Ceramic Market by Country, 2022 - 2028, USD Million
TABLE 130 Europe Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 131 Europe Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 132 Europe Chronic Pain Market by Country, 2018 - 2021, USD Million
TABLE 133 Europe Chronic Pain Market by Country, 2022 - 2028, USD Million
TABLE 134 Europe Urinary & Fecal Incontinence Market by Country, 2018 - 2021, USD Million
TABLE 135 Europe Urinary & Fecal Incontinence Market by Country, 2022 - 2028, USD Million
TABLE 136 Europe Migraine Market by Country, 2018 - 2021, USD Million
TABLE 137 Europe Migraine Market by Country, 2022 - 2028, USD Million
TABLE 138 Europe Failed Back Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 139 Europe Failed Back Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 140 Europe Parkinson Disease Market by Country, 2018 - 2021, USD Million
TABLE 141 Europe Parkinson Disease Market by Country, 2022 - 2028, USD Million
TABLE 142 Europe Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 143 Europe Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 144 Europe Tremor Market by Country, 2018 - 2021, USD Million
TABLE 145 Europe Tremor Market by Country, 2022 - 2028, USD Million
TABLE 146 Europe Depression Market by Country, 2018 - 2021, USD Million
TABLE 147 Europe Depression Market by Country, 2022 - 2028, USD Million
TABLE 148 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 149 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 150 Europe Neuromodulation Market by Country, 2018 - 2021, USD Million
TABLE 151 Europe Neuromodulation Market by Country, 2022 - 2028, USD Million
TABLE 152 Germany Neuromodulation Market, 2018 - 2021, USD Million
TABLE 153 Germany Neuromodulation Market, 2022 - 2028, USD Million
TABLE 154 Germany Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 155 Germany Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 156 Germany Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 157 Germany Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 158 Germany Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 159 Germany Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 160 UK Neuromodulation Market, 2018 - 2021, USD Million
TABLE 161 UK Neuromodulation Market, 2022 - 2028, USD Million
TABLE 162 UK Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 163 UK Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 164 UK Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 165 UK Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 166 UK Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 167 UK Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 168 France Neuromodulation Market, 2018 - 2021, USD Million
TABLE 169 France Neuromodulation Market, 2022 - 2028, USD Million
TABLE 170 France Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 171 France Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 172 France Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 173 France Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 174 France Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 175 France Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 176 Russia Neuromodulation Market, 2018 - 2021, USD Million
TABLE 177 Russia Neuromodulation Market, 2022 - 2028, USD Million
TABLE 178 Russia Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 179 Russia Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 180 Russia Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 181 Russia Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 182 Russia Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 183 Russia Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 184 Spain Neuromodulation Market, 2018 - 2021, USD Million
TABLE 185 Spain Neuromodulation Market, 2022 - 2028, USD Million
TABLE 186 Spain Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 187 Spain Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 188 Spain Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 189 Spain Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 190 Spain Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 191 Spain Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 192 Italy Neuromodulation Market, 2018 - 2021, USD Million
TABLE 193 Italy Neuromodulation Market, 2022 - 2028, USD Million
TABLE 194 Italy Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 195 Italy Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 196 Italy Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 197 Italy Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 198 Italy Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 199 Italy Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 200 Rest of Europe Neuromodulation Market, 2018 - 2021, USD Million
TABLE 201 Rest of Europe Neuromodulation Market, 2022 - 2028, USD Million
TABLE 202 Rest of Europe Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 203 Rest of Europe Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 204 Rest of Europe Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 205 Rest of Europe Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 206 Rest of Europe Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 207 Rest of Europe Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 208 Asia Pacific Neuromodulation Market, 2018 - 2021, USD Million
TABLE 209 Asia Pacific Neuromodulation Market, 2022 - 2028, USD Million
TABLE 210 Asia Pacific Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 211 Asia Pacific Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 212 Asia Pacific Internal Market by Country, 2018 - 2021, USD Million
TABLE 213 Asia Pacific Internal Market by Country, 2022 - 2028, USD Million
TABLE 214 Asia Pacific External Market by Country, 2018 - 2021, USD Million
TABLE 215 Asia Pacific External Market by Country, 2022 - 2028, USD Million
TABLE 216 Asia Pacific Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 217 Asia Pacific Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 218 Asia Pacific Metallic Market by Country, 2018 - 2021, USD Million
TABLE 219 Asia Pacific Metallic Market by Country, 2022 - 2028, USD Million
TABLE 220 Asia Pacific Polymeric Market by Country, 2018 - 2021, USD Million
TABLE 221 Asia Pacific Polymeric Market by Country, 2022 - 2028, USD Million
TABLE 222 Asia Pacific Ceramic Market by Country, 2018 - 2021, USD Million
TABLE 223 Asia Pacific Ceramic Market by Country, 2022 - 2028, USD Million
TABLE 224 Asia Pacific Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 225 Asia Pacific Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 226 Asia Pacific Chronic Pain Market by Country, 2018 - 2021, USD Million
TABLE 227 Asia Pacific Chronic Pain Market by Country, 2022 - 2028, USD Million
TABLE 228 Asia Pacific Urinary & Fecal Incontinence Market by Country, 2018 - 2021, USD Million
TABLE 229 Asia Pacific Urinary & Fecal Incontinence Market by Country, 2022 - 2028, USD Million
TABLE 230 Asia Pacific Migraine Market by Country, 2018 - 2021, USD Million
TABLE 231 Asia Pacific Migraine Market by Country, 2022 - 2028, USD Million
TABLE 232 Asia Pacific Failed Back Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 233 Asia Pacific Failed Back Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 234 Asia Pacific Parkinson Disease Market by Country, 2018 - 2021, USD Million
TABLE 235 Asia Pacific Parkinson Disease Market by Country, 2022 - 2028, USD Million
TABLE 236 Asia Pacific Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 237 Asia Pacific Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 238 Asia Pacific Tremor Market by Country, 2018 - 2021, USD Million
TABLE 239 Asia Pacific Tremor Market by Country, 2022 - 2028, USD Million
TABLE 240 Asia Pacific Depression Market by Country, 2018 - 2021, USD Million
TABLE 241 Asia Pacific Depression Market by Country, 2022 - 2028, USD Million
TABLE 242 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 243 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 244 Asia Pacific Neuromodulation Market by Country, 2018 - 2021, USD Million
TABLE 245 Asia Pacific Neuromodulation Market by Country, 2022 - 2028, USD Million
TABLE 246 China Neuromodulation Market, 2018 - 2021, USD Million
TABLE 247 China Neuromodulation Market, 2022 - 2028, USD Million
TABLE 248 China Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 249 China Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 250 China Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 251 China Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 252 China Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 253 China Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 254 Japan Neuromodulation Market, 2018 - 2021, USD Million
TABLE 255 Japan Neuromodulation Market, 2022 - 2028, USD Million
TABLE 256 Japan Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 257 Japan Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 258 Japan Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 259 Japan Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 260 Japan Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 261 Japan Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 262 India Neuromodulation Market, 2018 - 2021, USD Million
TABLE 263 India Neuromodulation Market, 2022 - 2028, USD Million
TABLE 264 India Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 265 India Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 266 India Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 267 India Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 268 India Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 269 India Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 270 South Korea Neuromodulation Market, 2018 - 2021, USD Million
TABLE 271 South Korea Neuromodulation Market, 2022 - 2028, USD Million
TABLE 272 South Korea Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 273 South Korea Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 274 South Korea Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 275 South Korea Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 276 South Korea Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 277 South Korea Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 278 Singapore Neuromodulation Market, 2018 - 2021, USD Million
TABLE 279 Singapore Neuromodulation Market, 2022 - 2028, USD Million
TABLE 280 Singapore Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 281 Singapore Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 282 Singapore Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 283 Singapore Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 284 Singapore Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 285 Singapore Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 286 Malaysia Neuromodulation Market, 2018 - 2021, USD Million
TABLE 287 Malaysia Neuromodulation Market, 2022 - 2028, USD Million
TABLE 288 Malaysia Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 289 Malaysia Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 290 Malaysia Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 291 Malaysia Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 292 Malaysia Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 293 Malaysia Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 294 Rest of Asia Pacific Neuromodulation Market, 2018 - 2021, USD Million
TABLE 295 Rest of Asia Pacific Neuromodulation Market, 2022 - 2028, USD Million
TABLE 296 Rest of Asia Pacific Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 297 Rest of Asia Pacific Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 298 Rest of Asia Pacific Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 299 Rest of Asia Pacific Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 300 Rest of Asia Pacific Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 301 Rest of Asia Pacific Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 302 LAMEA Neuromodulation Market, 2018 - 2021, USD Million
TABLE 303 LAMEA Neuromodulation Market, 2022 - 2028, USD Million
TABLE 304 LAMEA Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 305 LAMEA Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 306 LAMEA Internal Market by Country, 2018 - 2021, USD Million
TABLE 307 LAMEA Internal Market by Country, 2022 - 2028, USD Million
TABLE 308 LAMEA External Market by Country, 2018 - 2021, USD Million
TABLE 309 LAMEA External Market by Country, 2022 - 2028, USD Million
TABLE 310 LAMEA Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 311 LAMEA Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 312 LAMEA Metallic Market by Country, 2018 - 2021, USD Million
TABLE 313 LAMEA Metallic Market by Country, 2022 - 2028, USD Million
TABLE 314 LAMEA Polymeric Market by Country, 2018 - 2021, USD Million
TABLE 315 LAMEA Polymeric Market by Country, 2022 - 2028, USD Million
TABLE 316 LAMEA Ceramic Market by Country, 2018 - 2021, USD Million
TABLE 317 LAMEA Ceramic Market by Country, 2022 - 2028, USD Million
TABLE 318 LAMEA Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 319 LAMEA Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 320 LAMEA Chronic Pain Market by Country, 2018 - 2021, USD Million
TABLE 321 LAMEA Chronic Pain Market by Country, 2022 - 2028, USD Million
TABLE 322 LAMEA Urinary & Fecal Incontinence Market by Country, 2018 - 2021, USD Million
TABLE 323 LAMEA Urinary & Fecal Incontinence Market by Country, 2022 - 2028, USD Million
TABLE 324 LAMEA Migraine Market by Country, 2018 - 2021, USD Million
TABLE 325 LAMEA Migraine Market by Country, 2022 - 2028, USD Million
TABLE 326 LAMEA Failed Back Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 327 LAMEA Failed Back Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 328 LAMEA Parkinson Disease Market by Country, 2018 - 2021, USD Million
TABLE 329 LAMEA Parkinson Disease Market by Country, 2022 - 2028, USD Million
TABLE 330 LAMEA Epilepsy Market by Country, 2018 - 2021, USD Million
TABLE 331 LAMEA Epilepsy Market by Country, 2022 - 2028, USD Million
TABLE 332 LAMEA Tremor Market by Country, 2018 - 2021, USD Million
TABLE 333 LAMEA Tremor Market by Country, 2022 - 2028, USD Million
TABLE 334 LAMEA Depression Market by Country, 2018 - 2021, USD Million
TABLE 335 LAMEA Depression Market by Country, 2022 - 2028, USD Million
TABLE 336 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 337 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 338 LAMEA Neuromodulation Market by Country, 2018 - 2021, USD Million
TABLE 339 LAMEA Neuromodulation Market by Country, 2022 - 2028, USD Million
TABLE 340 Brazil Neuromodulation Market, 2018 - 2021, USD Million
TABLE 341 Brazil Neuromodulation Market, 2022 - 2028, USD Million
TABLE 342 Brazil Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 343 Brazil Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 344 Brazil Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 345 Brazil Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 346 Brazil Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 347 Brazil Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 348 Argentina Neuromodulation Market, 2018 - 2021, USD Million
TABLE 349 Argentina Neuromodulation Market, 2022 - 2028, USD Million
TABLE 350 Argentina Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 351 Argentina Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 352 Argentina Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 353 Argentina Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 354 Argentina Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 355 Argentina Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 356 UAE Neuromodulation Market, 2018 - 2021, USD Million
TABLE 357 UAE Neuromodulation Market, 2022 - 2028, USD Million
TABLE 358 UAE Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 359 UAE Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 360 UAE Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 361 UAE Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 362 UAE Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 363 UAE Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 364 Saudi Arabia Neuromodulation Market, 2018 - 2021, USD Million
TABLE 365 Saudi Arabia Neuromodulation Market, 2022 - 2028, USD Million
TABLE 366 Saudi Arabia Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 367 Saudi Arabia Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 368 Saudi Arabia Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 369 Saudi Arabia Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 370 Saudi Arabia Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 371 Saudi Arabia Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 372 South Africa Neuromodulation Market, 2018 - 2021, USD Million
TABLE 373 South Africa Neuromodulation Market, 2022 - 2028, USD Million
TABLE 374 South Africa Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 375 South Africa Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 376 South Africa Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 377 South Africa Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 378 South Africa Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 379 South Africa Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 380 Nigeria Neuromodulation Market, 2018 - 2021, USD Million
TABLE 381 Nigeria Neuromodulation Market, 2022 - 2028, USD Million
TABLE 382 Nigeria Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 383 Nigeria Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 384 Nigeria Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 385 Nigeria Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 386 Nigeria Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 387 Nigeria Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 388 Rest of LAMEA Neuromodulation Market, 2018 - 2021, USD Million
TABLE 389 Rest of LAMEA Neuromodulation Market, 2022 - 2028, USD Million
TABLE 390 Rest of LAMEA Neuromodulation Market by Technology, 2018 - 2021, USD Million
TABLE 391 Rest of LAMEA Neuromodulation Market by Technology, 2022 - 2028, USD Million
TABLE 392 Rest of LAMEA Neuromodulation Market by Biomaterial, 2018 - 2021, USD Million
TABLE 393 Rest of LAMEA Neuromodulation Market by Biomaterial, 2022 - 2028, USD Million
TABLE 394 Rest of LAMEA Neuromodulation Market by Application, 2018 - 2021, USD Million
TABLE 395 Rest of LAMEA Neuromodulation Market by Application, 2022 - 2028, USD Million
TABLE 396 Key Information – Medtronic PLC
TABLE 397 Key Information – LivaNova PLC
TABLE 398 key Information – Boston Scientific Corporation
TABLE 399 Key Information – Abbott Laboratories
TABLE 400 Key Information – Nevro Corporation
TABLE 401 key Information – NeuroSigma, Inc.
TABLE 402 Key Information – NeuroPace, Inc.
TABLE 403 Key Information – Neuronetics, Inc.
TABLE 404 Key Information – MicroTransponder Inc.
TABLE 405 Key Information – Bioventus Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Global Neuromodulation Market Share by Technology, 2021
FIG 5 Global Neuromodulation Market Share by Technology, 2028
FIG 6 Global Neuromodulation Market by Technology, 2018 - 2028, USD Million
FIG 7 Global Neuromodulation Market Share by Biomaterial, 2021
FIG 8 Global Neuromodulation Market Share by Biomaterial, 2028
FIG 9 Global Neuromodulation Market by Biomaterial, 2018 - 2028, USD Million
FIG 10 Global Neuromodulation Market Share by Application, 2021
FIG 11 Global Neuromodulation Market Share by Application, 2028
FIG 12 Global Neuromodulation Market by Application, 2018 - 2028, USD Million
FIG 13 Global Neuromodulation Market Share by Region, 2021
FIG 14 Global Neuromodulation Market Share by Region, 2028
FIG 15 Global Neuromodulation Market by Region, 2018 - 2028, USD Million
FIG 16 Recent strategies and developments: Medtronic PLC
FIG 17 Recent strategies and developments: Bioventus Inc.